[ESPR] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
30-Dec-2012
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- -8.55%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/02 31/12/01 CAGR
Revenue 0 0 4,977,012 0 0 0 0 -
PBT -49,784 -36,375 -26,088 -11,742 -10,817 -28,726 -24,931 5.06%
Tax 1,060 229 1,131 1,403 501 2,071 468 6.00%
NP -49,784 -36,375 -26,088 -11,742 -10,817 -28,726 -24,931 5.06%
Tax Rate - - - - - - - -
Total Cost 49,784 36,375 5,003,100 11,742 10,817 28,726 24,931 5.06%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/02 31/12/01 CAGR
NP Margin 0.00 0.00 -0.52 0.00 0.00 0.00 0.00 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/02 31/12/01 CAGR
EPS -2.26 -2.22 -1.71 -1.22 -1.13 -6.86 -6.38 -7.14%
EPS Diluted -2.26 -2.22 -1.70 -1.22 -1.13 -6.86 -6.38 -7.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.